Naranjo, A.-I.; González-Gómez, M.-J.; Baladrón, V.; Laborda, J.; Nueda, M.-L.
Different Expression Levels of DLK2 Inhibit NOTCH Signaling and Inversely Modulate MDA-MB-231 Breast Cancer Tumor Growth In Vivo. Int. J. Mol. Sci. 2022, 23, 1554.
https://doi.org/10.3390/ijms23031554
AMA Style
Naranjo A-I, González-Gómez M-J, Baladrón V, Laborda J, Nueda M-L.
Different Expression Levels of DLK2 Inhibit NOTCH Signaling and Inversely Modulate MDA-MB-231 Breast Cancer Tumor Growth In Vivo. International Journal of Molecular Sciences. 2022; 23(3):1554.
https://doi.org/10.3390/ijms23031554
Chicago/Turabian Style
Naranjo, Ana-Isabel, MarÃa-Julia González-Gómez, Victoriano Baladrón, Jorge Laborda, and MarÃa-Luisa Nueda.
2022. "Different Expression Levels of DLK2 Inhibit NOTCH Signaling and Inversely Modulate MDA-MB-231 Breast Cancer Tumor Growth In Vivo" International Journal of Molecular Sciences 23, no. 3: 1554.
https://doi.org/10.3390/ijms23031554
APA Style
Naranjo, A.-I., González-Gómez, M.-J., Baladrón, V., Laborda, J., & Nueda, M.-L.
(2022). Different Expression Levels of DLK2 Inhibit NOTCH Signaling and Inversely Modulate MDA-MB-231 Breast Cancer Tumor Growth In Vivo. International Journal of Molecular Sciences, 23(3), 1554.
https://doi.org/10.3390/ijms23031554
